for Investors
for Partners
for Media
Main contents starts here
What's New
- September 2, 2010
Orexigen® Therapeutics and Takeda Enter into Partnership to Commercialize Contrave® in North America - August 31, 2010
Takeda Announces New Initiative in Cell Culture-Based Influenza Vaccines - August 20, 2010
Approval of Additional Indication of NESINA®: Combination Therapy with Thiazolidinediones for Type 2 Diabetes in Japan
Stock Performance
TSE 9/2 15:00
- Last
- 3,890
- Change
- +35
